CStone Pharmaceuticals

About:

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Website: http://www.cstonepharma.com/

Top Investors: ARCH Venture Partners, GIC, Hillhouse Investment, HongShan, Oriza Seed Capital (Oriza Yuandian)

Description:

CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.

Total Funding Amount:

$413M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2015-12-23

Contact Email:

cstone(AT)cstonepharma.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2022-03-28

IPO Status:

Public

© 2025 bioDAO.ai